Annie Collins

Annie completed her B.Sc.(Hons) in physiology at the University of British Columbia in Vancouver, Canada in 2017. Her honour’s thesis work with Douglas Allan focused on the characterization of genetic regulatory elements important for neural development in fruit flies. Annie went on to complete her medical degree with distinction at the University of Oxford in 2022 in the accelerated graduate entry programme. Wanting to apply her clinical knowledge to research, she joined UMass Chan in 2023 as a postdoc, working jointly in the labs of Robert Brown and Jonathan Watts. Annie holds a Milton Safenowitz Postdoctoral Fellowship from the ALS Association, and her work focuses on the development of therapeutic oligonucleotides, with particular focus on the development of treatments for sporadic ALS.